U.S. markets closed

TransEnterix, Inc. (TRXC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.3540+0.0037 (+1.06%)
At close: 4:00PM EDT

0.3500 -0.00 (-1.13%)
After hours: 6:31PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close0.3503
Open0.3550
Bid0.3502 x 800
Ask0.3548 x 1200
Day's Range0.3420 - 0.3600
52 Week Range0.2800 - 8.1900
Volume1,141,173
Avg. Volume5,886,232
Market Cap35.356M
Beta (5Y Monthly)2.44
PE Ratio (TTM)N/A
EPS (TTM)-4.8030
Earnings DateAug 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities
    Business Wire

    TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Hackensack Meridian Health Pascack Valley Medical Center, a hospital in New Jersey, successfully completed its first surgical procedures using the Intelligent Surgical UnitTM (ISU™). The technology previously received FDA clearance, and currently enables machine vision capabilities on the SenhanceⓇ Surgical System. The patients were treated by Dr. Amit Trivedi, Chair of Surgery at Hackensack Meridian Health Pascack Valley Medical Center, and his team in multiple general surgery procedures.

  • TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System
    Business Wire

    TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it established the first training center for the Senhance® Surgical System in the Asia-Pacific region in Japan at the Saitama Medical University International Medical Center in the Greater Tokyo Area.

  • TransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment Conference
    Business Wire

    TransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment Conference

    TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the H. C. Wainwright 22nd Annual Global Investment Conference. The presentation is scheduled to take place virtually at 3:00 PM Eastern, Tuesday, September 15, 2020.